MandellL.A., WunderinkR.G., AnzuetoA., BartlettJ.G., CampbellG.D., DeanN.C.Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults.Clin Infect Dis2007; 44(Suppl 2): S27–72.
2.
LimW.S., van der EerdenM.M., LaingR., BoersmaW.G., KaralusN., TownG.I.Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study.Thorax2003; 58: 377–82.
Caring for Australians with Renal Impairment (CARI).Evidence for peritonitis treatment and prophylaxis: treatment of peritoneal dialysis-associated peritonitis in adults.Nephrology (Carlton)2004; 9(Suppl 3): S91–S106.
6.
LarvinM., McMahonM.J.APACHE-II score for assessment and monitoring of acute pancreatitis.Lancet1989; 2: 201–5.
7.
RansonJ.H., PasternackB.S.Statistical methods for quantifying the severity of clinical acute pancreatitis.J Surg Res1977; 22: 79–91.
8.
YangC.Y., ChenT W., LinY.P., LinC.C., NgY.Y., YangW.C.Determinants of catheter loss following continuous ambulatory peritoneal dialysis peritonitis.Perit Dial Int2008; 28: 361–70.
9.
DombrosN., DratwaM., FerianiM., GokalR., HeimbürgerO., KredietR.; EBPG Expert Group on Peritoneal Dialysis. European best practice guidelines for peritoneal dialysis. 3 Peritoneal access.Nephrol Dial Transplant2005; 20(Suppl 9): ix8–ix12.
10.
KrishnanM., ThodisE., IkonomopoulosD., VidgenE., ChuM., BargmanJ.M.Predictors of outcome following bacterial peritonitis in peritoneal dialysis.Perit Dial Int2002; 22: 573–81.
11.
ChowK.M., SzetoC.C., CheungK.K., LeungC.B., WongS.S., LawM.C.Predictive value of dialysate cell counts in peritonitis complicating peritoneal dialysis.Clin J Am Soc Nephrol2006; 1: 768–73.
12.
WangH.H., LinC.Y.Interleukin-12 and -18 levels in peritoneal dialysate effluent correlate with the outcome of peritonitis in patients undergoing peritoneal dialysis: implications for the type I/type II T-cell immune response.Am J Kidney Dis2005; 46: 328–38.
13.
McCullyM.L., BarojaM.L., ChauT.A., KainA.K., BarraL., SalgadoA.Receptor-interacting protein 2 is a marker for resolution of peritoneal dialysis-associated peritonitis.Kidney Int2007; 72: 1273–81.
14.
VlaanderenK., BosH.J., de FijterC.W., OeL.P., van der MeulenJ., VerbrughH.A.Short dwell times reduce the local defense mechanism of chronic peritoneal dialysis patients.Nephron1991; 57: 29–35.
15.
Koziol-MontewkaM., KsiazekA., JanickaL., BaranowiczI.Serial cytokine changes in peritoneal effluent and plasma during peritonitis in patients on continuous ambulatory peritoneal dialysis (CAPD).Inflamm Res1997; 46: 132–6.
16.
ChowK.M., WongW.S., ChowV.C., WongT.Y., ChanN.P., LiP.K.Role of macrophages in tuberculous peritonitis: longitudinal follow-up of 16 continuous ambulatory peritoneal dialysis patients.Hong Kong J Nephrol2002; 4: 90–4.
